Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enobosarm for muscle wasting in NSCLC (POWER1)
NCT01355497Phase 3Completed
- Sponsor
- GTx
- Start
- Jul 2011
- Primary completion
- May 2013
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of enobosarm in muscle atrophy, sponsored by GTx. Started Jul 2011; status: completed.
02
Drugs
enobosarm
03
Conditions
muscle atrophy
Beyond the preview
Go deeper on NCT01355497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01355497.